首页> 美国卫生研究院文献>International Journal of Nanomedicine >Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis
【2h】

Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis

机译:细胞穿透性肽转录因子融合蛋白的细胞内递送及其在选择性成骨中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein-transduction technology has been attempted to deliver macromolecular materials, including protein, nucleic acids, and polymeric drugs, for either diagnosis or therapeutic purposes. Herein, fusion protein composed of an arginine-rich cell-penetrating peptide, termed low-molecular-weight protamine (LMWP), and a transcriptional coactivator with a PDZ-binding motif (TAZ) protein was prepared and applied in combination with biomaterials to increase bone-forming capacity. TAZ has been recently identified as a specific osteogenic stimulating transcriptional coactivator in human mesenchymal stem cell (hMSC) differentiation, while simultaneously blocking adipogenic differentiation. However, TAZ by itself cannot penetrate the cells, and thus needs a transfection tool for translocalization. The LMWP-TAZ fusion proteins were efficiently translocalized into the cytosol of hMSCs. The hMSCs treated with cell-penetrating LMWP-TAZ exhibited increased expression of osteoblastic genes and protein, producing significantly higher quantities of mineralized matrix compared to free TAZ. In contrast, adipogenic differentiation of the hMSCs was blocked by treatment of LMWP-TAZ fusion protein, as reflected by reduced marker-protein expression, adipocyte fatty acid-binding protein 2, and peroxisome proliferator-activated receptor-γ messenger ribonucleic acid levels. LMWP-TAZ was applied in alginate gel for the purpose of localization and controlled release. The LMWP-TAZ fusion protein-loaded alginate gel matrix significantly increased bone formation in rabbit calvarial defects compared with alginate gel matrix mixed with free TAZ protein. The protein transduction of TAZ fused with cell-penetrating LMWP peptide was able selectively to stimulate osteogenesis in vitro and in vivo. Taken together, this fusion protein-transduction technology for osteogenic protein can thus be applied in combination with biomaterials for tissue regeneration and controlled release for tissue-engineering purposes.
机译:为了诊断或治疗目的,已经尝试了蛋白质转导技术来递送大分子物质,包括蛋白质,核酸和聚合药物。在此,制备了由富含精氨酸的细胞穿透肽,称为低分子量鱼精蛋白(LMWP)和具有PDZ结合基序(TAZ)蛋白的转录共激活因子组成的融合蛋白,并与生物材料结合使用以增加骨形成能力。 TAZ最近已被确定为人类间充质干细胞(hMSC)分化中的一种特定的成骨刺激性转录共激活因子,同时阻断了脂肪形成的分化。但是,TAZ本身不能穿透细胞,因此需要转染工具进行转位。 LMWP-TAZ融合蛋白被有效地转移到hMSCs的细胞质中。与游离TAZ相比,用细胞穿透性LMWP-TAZ处理的hMSC表现出成骨细胞基因和蛋白质的表达增加,产生大量矿化基质。相比之下,hMSC的成脂分化被LMWP-TAZ融合蛋白的处理所阻断,这通过减少的标志物蛋白表达,脂肪细胞脂肪酸结合蛋白2和过氧化物酶体增殖物激活的受体-γ信使核糖核酸水平来反映。为了定位和控制释放,将LMWP-TAZ应用于藻酸盐凝胶中。与藻酸盐凝胶基质与游离TAZ蛋白混合后,载有LMWP-TAZ融合蛋白的藻酸盐凝胶基质显着增加了兔颅骨缺损的骨形成。 TAZ与穿透细胞的LMWP肽融合的蛋白转导能够选择性地在体外和体内刺激成骨作用。综上所述,这种用于成骨蛋白的融合蛋白转导技术可与生物材料结合用于组织再生和控释,以用于组织工程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号